1989

Scott Snyder sent this email about his new position at a division of Johnson & Johnson: "The job is with a small, fast-growing company that competes in cellular therapy. Think biotech, and you're pretty close. The company has developed a novel technology to treat autoimmune diseases, organ transplant rejection and certain cancers where the immune system needs to be altered. They found a way to adjust the body's sometimes overactive immune response to its own tissues by using a combination of drugs and ultraviolet light, which is applied to a patient's white blood cells via a special machine. It is sometimes the only way to save the lives of certain patients who don't respond to standard treatments like steroids or immunosupressant drugs. Consumer package goods marketing it's not, but it's change-the-world stuff, with significant growth potential. I'll be vice president of worldwide marketing, which includes the United States and Europe, with emerging markets waiting to be tapped."

Mark Dancer, vice president and principal at Pembroke Consulting, will drive business development and direct local operations at the firm's new office in Northbrook, Ill.